Centene (NYSE:CNC) Updates FY 2025 Earnings Guidance

Centene (NYSE:CNC) updated its FY 2025 earnings guidance on Wednesday. The company provided earnings per share (EPS) guidance of 7.250- for the period, compared to the consensus estimate of 7.950. The company issued revenue guidance of -.

Centene Stock Down 0.5 %

Centene stock opened at $60.23 on Friday. The company has a market capitalization of $29.88 billion, a P/E ratio of 9.65, a P/E/G ratio of 0.80 and a beta of 0.40. The firm has a 50 day moving average price of $59.98 and a 200-day moving average price of $62.86. The company has a quick ratio of 1.10, a current ratio of 1.11 and a debt-to-equity ratio of 0.70. Centene has a twelve month low of $55.03 and a twelve month high of $80.59.

Centene (NYSE:CNC) last released its quarterly earnings data on Tuesday, February 4th. The company reported $0.80 earnings per share for the quarter, beating analysts’ consensus estimates of $0.49 by $0.31. The business had revenue of $40.81 billion during the quarter, compared to analyst estimates of $38.78 billion. Centene had a net margin of 2.03% and a return on equity of 13.85%. Centene’s revenue was up 3.4% compared to the same quarter last year. During the same period in the previous year, the business earned $0.45 EPS. As a group, equities analysts predict that Centene will post 6.86 EPS for the current year.

Analyst Upgrades and Downgrades

Several equities research analysts have issued reports on the stock. Barclays lifted their target price on shares of Centene from $91.00 to $93.00 and gave the company an “overweight” rating in a research report on Friday, December 13th. Jefferies Financial Group lowered shares of Centene from a “hold” rating to an “underperform” rating and cut their target price for the stock from $68.00 to $52.00 in a research report on Tuesday, December 10th. Argus downgraded Centene from a “buy” rating to a “hold” rating in a research report on Thursday, February 6th. Truist Financial reduced their price objective on Centene from $89.00 to $84.00 and set a “buy” rating on the stock in a research report on Friday, December 13th. Finally, UBS Group upgraded Centene from a “neutral” rating to a “buy” rating and boosted their target price for the stock from $79.00 to $80.00 in a research report on Friday, December 13th. One investment analyst has rated the stock with a sell rating, five have given a hold rating and ten have given a buy rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $79.92.

About Centene

Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children’s health insurance program, foster care, medicare-medicaid plans, long-term services and support.